Chlorophenylpiperazine (mCPP) is a piperazine metabolite of several antidepressants and anxiolytics, acting on serotonin and dopamine receptors, and is tracked as an important active metabolite and potential impurity in manufacturing routes of its parent drugs. Simson Pharma's Chlorophenylpiperazine reference standard supports metabolite identification and impurity control.
Simson Pharma Global Ltd. (UK) and Simson Pharma Global LLC (USA) supply high-quality Chlorophenylpiperazine Reference Standards, pharmacopoeial reference materials, and its related impurities to pharmaceutical manufacturers, CROs, analytical laboratories, universities, and regulatory organizations worldwide. To service the Europe and America market efficiently, Simson Pharma Limited has set up Simson Pharma Global Ltd. in United Kingdom and Simson Pharma Global LLC in USA respectively.
